|
1.Sharp, D. B.; Hamilton, C. S., Derivatives of 1, 2, 4-Triazole and of Pyrazole. J. Am. Chem. Soc. 1946, 68 (4), 588-91. 2.Ghannoum, M. A.; Eweiss, N. F.; Bahajaj, A. A.; Qureshi, M. A., Antimicrobial activity of some thiol-containing heterocycles. Microbios 1983, 37 (149-150), 151-9. 3.Collin, X.; Sauleau, A.; Coulon, J., 1,2,4-Triazolo mercapto and aminonitriles as potent antifungal agents. Bioorg. Med. Chem. Lett. 2003, 13 (15), 2601-5. 4.Mange, Y. J.; Isloor, A. M.; Malladi, S.; Isloor, S.; Fun, H. K., Synthesis and antimicrobial activities of some novel 1,2,4-triazole derivatives. Arab J Chem 2013, 6 (2), 177-81. 5.Gajanan Khanage, S.; Raju, A.; Baban Mohite, P.; Bhanudas Pandhare, R., Analgesic activity of some 1,2,4-triazole heterocycles clubbed with pyrazole, tetrazole, isoxazole and pyrimidine. Advanced pharmaceutical bulletin 2013, 3 (1), 13-8. 6.Zhang, Q.; Peng, Y.; Wang, X. I.; Keenan, S. M.; Arora, S.; Welsh, W. J., Highly potent triazole-based tubulin polymerization inhibitors. J. Med. Chem.2007, 50 (4), 749-54. 7.Romagnoli, R.; Baraldi, P. G.; Cruz-Lopez, O.; Lopez Cara, C.; Carrion, M. D.; Brancale, A.; Hamel, E.; Chen, L.; Bortolozzi, R.; Basso, G.; Viola, G., Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues. J. Med. Chem.2010, 53 (10), 4248-58. 8.Romagnoli, R.; Baraldi, P. G.; Cruz-Lopez, O.; Cara, C. L.; Carrion, M. D.; Brancale, A.; Hamel, E.; Chen, L. C.; Bortolozzi, R.; Basso, G.; Viola, G., Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues. J. Med. Chem. 2010, 53 (10), 4248-58. 9.Sadana, A. K.; Mirza, Y.; Aneja, K. R.; Prakash, O., Hypervalent iodine mediated synthesis of 1-aryl/hetryl-1,2,4-triazolo[4,3-a] pyridines and 1-aryl/hetryl 5-methyl-1,2,4-triazolo[4,3-a]quinolines as antibacterial agents. Eur J. Med. Chem. 2003, 38 (5), 533-6. 10.Vu, C. B.; Shields, P.; Peng, B.; Kumaravel, G.; Jin, X. W.; Phadke, D.; Wang, J.; Engber, T.; Ayyub, E.; Petter, R. C., Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A(2a) receptor antagonists. Bioorg. Med. Chem. Lett. 2004, 14 (19), 4835-8. 11.Bussolari, J. C.; Panzica, R. P., Synthesis and anti-HIV evaluation of 2 '',3 ''-dideoxy imidazo- and nu-triazolo[4,5-d]pyridazine nucleosides. Bioorg. Med. Chem. Lett. 1999, 7 (11), 2373-9. 12.Yao, G.; Haque, S.; Sha, L.; Kumaravel, G.; Wang, J.; Engber, T. M.; Whalley, E. T.; Conlon, P. R.; Chang, H.; Kiesman, W. F.; Petter, R. C., Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists. Bioorg. Med. Chem. Lett. 2005, 15 (3), 511-5. 13.Reddy, C. S.; Rao, L. S.; Rajesi-Kumar, G.; Nagaraj, A., Synthesis of new 1,2,4-triazole[3,4-b][1,3,4]thiadiazoles bearing pyrazole as potent antimicrobial agents. Chem Pharm Bull 2010, 58 (10), 1328-31. 14.(a) Boeglin, D.; Cantel, S.; Heitz, A.; Martinez, J.; Fehrentz, J. A., Solution and solid-supported synthesis of 3,4,5-trisubstituted 1,2,4-triazole-based peptidomimetics. Org. Lett. 2003, 5 (23), 4465-8; (b) Bibian, M.; Blayo, A. L.; Moulin, A.; Martinez, J.; Fehrentz, J. A., Multi-gram scale mercury-free synthesis of optically pure 3,4,5-trisubstituted 1,2,4-triazoles using silver benzoate. Tetrahedron Lett. 2010, 51 (19), 2660-3. 15.Deprez-Poulain, R. F.; Charton, J.; Leroux, V.; Deprez, B. P., Convenient synthesis of 4H-1,2,4-triazole-3-thiols using di-2-pyridylthionocarbonate. Tetrahedron Lett. 2007, 48 (46), 8157-62. 16.Lassig, D.; Lincke, J.; Krautscheid, H., Highly functionalised 3,4,5-trisubstituted 1,2,4-triazoles for future use as ligands in coordination polymers. Tetrahedron Lett. 2010, 51 (4), 653-6. 17.Abdel-Megeed, A. M.; Abdel-Rahman, H. A.; Alkaramany, G. E. S.; El-Gendy, M. A., Design, synthesis and molecular modeling study of acylated 1,2,4-triazole-3-acetates with potential anti-inflammatory activity. Eur J. Med. Chem.2009, 44 (1), 117-23. 18.Yeung, K. S.; Farkas, M. E.; Kadow, J. F.; Meanwell, N. A., A base-catalyzed, direct synthesis of 3,5-disubstituted 1,2,4-triazoles from nitriles and hydrazides. Tetrahedron Lett. 2005, 46 (19), 3429-32. 19.(a) Li, G.; Kakarla, R.; Gerritz, S. W., A fast and efficient bromination of isoxazoles and pyrazoles by microwave irradiation. Tetrahedron Lett. 2007, 48 (26), 4595-9; (b) Haddad, N.; Salvagno, A.; Busacca, C., Application of the palladium-catalyzed N-arylation of hydrazones to deactivated heteroaryl halides in the synthesis of pyrazoles. Tetrahedron Lett. 2004, 45 (30), 5935-7. 20.(a) Tanitame, A.; Oyamada, Y.; Ofuji, K.; Fujimoto, M.; Iwai, N.; Hiyama, Y.; Suzuki, K.; Ito, H.; Terauchi, H.; Kawasaki, M.; Nagai, K.; Wachi, M.; Yamagishi, J., Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives. J. Med. Chem.2004, 47 (14), 3693-6; (b) Liu, J. J.; Sun, J.; Fang, Y. B.; Yang, Y. A.; Jiao, R. H.; Zhu, H. L., Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors. Org. Biomol. Chem.2014, 12 (6), 998-1008. 21.Morimoto, K.; Makino, K.; Yamamoto, S.; Sakata, G., Synthesis of fluoromethyl, difluoromethyl and trifluoromethyl analogs of pyrazosulfuron-ethyl as herbicides. J. Heterocycl. Chem. 1990, 27 (3), 807-10. 22.Nitulescu, G. M.; Paunescu, H.; Draghici, C.; Missir, A. V.; Coman, O. A.; Fulga, I., Synthesis and pharmacological evaluation of some new pyrazole derivatives. Farmacia 2010, 58 (2), 190-7. 23.(a) Kumar, H.; Saini, D.; Jain, S.; Jain, N., Pyrazole scaffold: A remarkable tool in the development of anticancer agents. Eur J. Med. Chem. 2013, 70, 248-58; (b) Yuan, J. W.; Wang, S. F.; Luo, Z. L.; Qiu, H. Y.; Wang, P. F.; Zhang, X.; Yang, Y. A.; Yin, Y.; Zhang, F.; Zhu, H. L., Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents. Bioorg. Med. Chem. Lett. 2014, 24 (10), 2324-8. 24.(a) Park, H. J.; Lee, K.; Park, S. J.; Ahn, B.; Lee, J. C.; Cho, H.; Lee, K. I., Identification of antitumor activity of pyrazole oxime ethers. Bioorg. Med. Chem. Lett. 2005, 15 (13), 3307-12; (b) Park, H. J.; Lee, K.; Park, S. J.; Ahn, B.; Lee, J. C.; Cho, H.; Lee, K. I., Identification of antitumor activity of pyrazole oxime ethers. Bioorg. Med. Chem. Lett. 2005, 15 (13), 3307-12. 25.(a) Wen, K. S.; Lin, H. Y.; Huang, Y. Y.; Kaneko, K.; Takayama, H.; Kimura, M.; Juang, S. H.; Wong, F. F., Chemoselective synthesis, antiproliferative activities, and SAR study of 1H-pyrazol-5-yl-N,N-dimethylformamidines and pyrazolyl-2-azadienes. Med. Chem. Res. 2012, 21 (11), 3920-3928; (b) Cheng, K. M.; Huang, Y. Y.; Huang, J. J.; Kaneko, K.; Kimura, M.; Takayama, H.; Juang, S. H.; Wong, F. F., Synthesis and antiproliferative evaluation of N,N-disubstituted-N ''-[1-aryl-1H-pyrazol-5-yl]-methnimidamides. Bioorg. Med. Chem. Lett. 2010, 20 (22), 6781-4. 26.Menegatti, R.; Silva, G. M.; Zapata-Sudo, G.; Raimundo, J. M.; Sudo, R. T.; Barreiro, E. J.; Fraga, C. A., Design, synthesis, and pharmacological evaluation of new neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives with in vivo hypnotic and analgesic profile. Bioorg. Med. Chem. Lett. 2006, 14 (3), 632-40. 27.Jasmin, L.; Rabkin, S. D.; Granato, A.; Boudah, A.; Ohara, P. T., Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature 2003, 424 (6946), 316-20. 28.Ashton, C., Benzodiazepines: How they work and how to withdraw. The Ashton Manual, Aug 2002. 29.Wu, C.; Sun, D., GABA receptors in brain development, function, and injury. Metabolic brain disease 2014. 30.(a) Mendes, T. C.; Raimundo, J. M.; Nascimento-Junior, N. M.; Fraga, C. A.; Barreiro, E. J.; Sudo, R. T.; Zapata-Sudo, G., Sedation and antinociception induced by a new pyrazolo [3,4-b] pyrrolo [3,4-d] pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptors. Pharmacol Biochem Be 2009, 94 (1), 70-4; (b) Mendes, T. C.; Antunes, F.; Trachez, M. M.; Nascimento, N. M., Jr.; Fraga, C. A.; Barreiro, E. J.; Zapata-Sudo, G.; Sudo, R. T., Antihyperalgesic effects of a novel muscarinic agonist (LASSBio-873) in spinal nerve ligation in rats. Clin. Exp. Pharmacol. Physiol. 2013, 40 (7), 404-11. 31.Menegatti, R.; Silva, G. M. S.; Zapata-Sudo, G.; Raimundo, J. M.; Sudo, R. T.; Barreiro, E. J.; Fraga, C. A. M., Design, synthesis, and pharmacological evaluation of new neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives with in vivo hypnotic and analgesic profile. Bioorg. Med. Chem. Lett. 2006, 14 (3), 632-40. 32.Yates, P.; Eaton, P., Acceleration of the Diels-Alder reaction by aluminum chloride. J. Am. Chem. Soc. 1960, 82 (16), 4436-7. 33.Evans, D. A.; Johnson, J. S., Diels-Alder Reactions. Comprehensive asymmetric catalysis 1999, 3, 1177. 34.(a) Uehira, S.; Takaku, K.; Shinokubo, H.; Oshima, K., Regioselective reaction of dilithiated 1-alkynylsilanol with electrophiles. Synlett 1998, (10), 1096-8; (b) Behforouz, M.; Gu, Z. X.; Stelzer, L. S.; Ahmadian, M.; Haddad, J.; Scherschel, J. A., Diels-Alder reactions of N-silyloxy 1-azadienes. Tetrahedron Lett. 1997, 38 (13), 2211-4; (c) Mason, H. J.; Wu, X. M.; Schmitt, R.; Macor, J. E.; Yu, G. X., Synthesis of fused pyridopyrrolidine dione derivatives using hetero Diels-Alder reactions. Tetrahedron Lett. 2001, 42 (51), 8931-4. 35.Nascimento, N. M.; Mendes, T. C. F.; Leal, D. M.; Correa, C. M. N.; Sudo, R. T.; Zapata-Sudo, G.; Barreiro, E. J.; Fraga, C. A. M., Microwave-assisted synthesis and structure-activity relationships of neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives. Bioorg. Med. Chem. Lett. 2010, 20 (1), 74-7. 36.Cramer, R. D.; Patterson, D. E.; Bunce, J. D., Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110 (18), 5959-67. 37.(a) Diaz-Ortiz, A.; Carrillo, J. R.; Cossio, F. P.; Gomez-Escalonilla, M. J.; de la Hoz, A.; Moreno, A.; Prieto, P., Synthesis of pyrazolo[3,4-b]pyridines by cycloaddition reactions under microwave irradiation. Tetrahedron 2000, 56 (11), 1569-77; (b) Shawali, A. S., Reactions of heterocyclic-compounds with nitrilimines and their precursors. Chem. Rev. 1993, 93 (8), 2731-77. 38.Yamamoto, H.; Momiyama, N., Rich chemistry of nitroso compounds. Chemical communications 2005, (28), 3514-25. 39.(a) Glaser, R.; Murmann, R. K.; Barnes, C. L., Why do nitroso compounds dimerize while their oxime tautomers do not? A structural study of the trans-dimer of 2-chloro-2-methyl-3-nitrosobutane and higher level ab initio study of thermodynamic stabilities and electronic structures of isomers of diazene dioxides. J. Org. Chem. 1996, 61 (3), 1047-58; (b) Al-Shamkhani, Z. A. N.; Essa, A. H., Synthesis and spectroscopic studies of trans-bis-(3,5-dimethyl-4-nitrosopyrazole) dimer. Tetrahedron Lett. 2007, 48 (31), 5547-50. 40.Molander, G. A.; Cavalcanti, L. N., Nitrosation of aryl and heteroaryltrifluoroborates with nitrosonium tetrafluoroborate. J. Org. Chem. 2012, 77 (9), 4402-13. 41.Li, X.; Deng, H.; Zhu, X. Q.; Wang, X. X.; Liang, H.; Cheng, J. P., Establishment of the C-NO bond dissociation energy scale in solution and its application in analyzing the trend of NO transfer from C-nitroso compound to thiols. J. Org. Chem.2009, 74 (12), 4472-8. 42.Molander, G. A.; Cavalcanti, L. N., Nitrosation of aryl and heteroaryltrifluoroborates with nitrosonium tetrafluoroborate. J. Org. Chem.2012, 77 (9), 4402-13. 43.(a) Hunger, K., Industrial dyes: chemistry, properties, applications. John Wiley & Sons: 2007; (b) Yu, Y. L.; Nakano, M.; Ikeda, T., Directed bending of a polymer film by light - Miniaturizing a simple photomechanical system could expand its range of applications. Nature 2003, 425 (6954), 145-5; (c) Ikeda, T.; Tsutsumi, O., Optical Switching and image storage by means of azobenzene liquid-crystal films. Science 1995, 268 (5219), 1873-5. 44.(a) Carceller, E.; Salas, J.; Merlos, M.; Giral, M.; Ferrando, R.; Escamilla, I.; Ramis, J.; Garcia-Rafanell, J.; Forn, J., Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. J. Med. Chem.2001, 44 (18), 3001-13; (b) Brown, J. P.; Mcgarraugh, G. V.; Parkinson, T. M.; Wingard, R. E.; Onderdonk, A. B., Soluble functional polymers .3. A polymeric drug for treatment of inflammatory Bowel-Disease. J. Med. Chem.1983, 26 (9), 1300-7. 45.Saphier, S.; Haft, A.; Margel, S., Bacterial reduction as means for colonic drug delivery: Can other chemical groups provide an alternative to the azo bond? J. Med. Chem.2012, 55 (23), 10781-5. 46.Yu, B. C.; Shirai, Y.; Tour, J. M., Syntheses of new functionalized azobenzenes for potential molecular electronic devices. Tetrahedron 2006, 62 (44), 10303-10. 47.Zhao, R.; Tan, C. Y.; Xie, Y. H.; Gao, C. M.; Liu, H. X.; Jiang, Y. Y., One step synthesis of azo compounds from nitroaromatics and anilines. Tetrahedron Lett. 2011, 52 (29), 3805-9. 48.Casewit, C. J.; Goddard, W. A., Thermochemistry of trans-diimide and 1,1-diazene - abinitio studies. J. Am. Chem. Soc. 1980, 102 (12), 4057-62. 49.Ugi, I.; Domling, A.; Werner, B., Since 1995 the new chemistry of multicomponent reactions and their libraries, including their heterocyclic chemistry. J. Heterocycl. Chem. 2000, 37 (3), 647-58. 50.(a) Chang, C. H.; Tsai, H. J.; Huang, Y. Y.; Lin, H. Y.; Wang, L. Y.; Wu, T. S.; Wong, F. F., Selective synthesis of pyrazolo[3,4-d]pyrimidine, N-(1H-pyrazol-5-yl) formamide, or N-(1H-pyrazol-5-yl)formamidine derivatives from N-1-substituted-5-aminopyrazoles with new Vilsmeier-type reagents. Tetrahedron 2013, 69 (4), 1378-86; (b) Huang, Y. Y.; Wang, L. Y.; Chang, C. H.; Kuo, Y. H.; Kaneko, K.; Takayama, H.; Kimura, M.; Juang, S. H.; Wong, F. F., One-pot synthesis and antiproliferative evaluation of pyrazolo[3,4-d]pyrimidine derivatives. Tetrahedron 2012, 68 (47), 9658-64. 51.Pergolizzi, J. V., Jr.; Taylor, R., Jr.; Raffa, R. B.; Nalamachu, S.; Chopra, M., Fast-acting sublingual zolpidem for middle-of-the-night wakefulness. Sleep disorders 2014, 2014, 527109. 52.Gouda, M. A.; Berghot, M. A.; Shoeib, A. I.; Khalil, A. M., Synthesis and antimicrobial of new anthraquinone derivatives incorporating pyrazole moiety. Eur J. Med. Chem. 2010, 45 (5), 1843-8. 53.(a) Wang, L. Y.; Tseng, W. C.; Wu, T. S.; Kaneko, K.; Takayama, H.; Kimura, M.; Yang, W. C.; Bin Wu, J.; Juang, S. H.; Wong, F. F., Synthesis and antiproliferative evaluation of 3,5-disubstituted 1,2,4-triazoles containing flurophenyl and trifluoromethanephenyl moieties. Bioorg. Med. Chem. Lett. 2011, 21 (18), 5358-62; (b) Wang, L. Y.; Tseng, W. C.; Lin, H. Y.; Wong, F. F., An effective nitrilimine cycloaddition for the synthesis of 1,3,5-trisubstituted 1,2,4-triazoles from oximes with hydrazonoyl hydrochlorides. Synlett 2011, (10), 1467-71; (c) Tseng, W. C.; Wang, L. Y.; Wu, T. S.; Wong, F. F., ''One-flask'' synthesis to 3,5-disubstituted 1,2,4-triazoles from aldehydes with hydrazonoyl hydrochlorides via 1,3-dipolar cycloaddition. Tetrahedron 2011, 67 (29), 5339-45. 54.(a) Pfefferkorn, J. A.; Choi, C.; Larsen, S. D.; Auerbach, B.; Hutchings, R.; Park, W.; Askew, V.; Dillon, L.; Hanselman, J. C.; Lin, Z. W.; Lu, G. H.; Robertson, A.; Sekerke, C.; Harris, M. S.; Pavlovsky, A.; Bainbridge, G.; Caspers, N.; Kowala, M.; Tait, B. D., Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: Discovery of (3R,5R)-7-[2-(4-Fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemia. J. Med. Chem.2008, 51 (1), 31-45; (b) Silvestri, R.; Cascio, M. G.; La Regina, G.; Piscitelli, F.; Lavecchia, A.; Brizzi, A.; Pasquini, S.; Botta, M.; Novellino, E.; Di Marzo, V.; Corelli, F., Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. J. Med. Chem. 2008, 51 (6), 1560-76; (c) Pinto, D. J. P.; Orwat, M. J.; Koch, S.; Rossi, K. A.; Alexander, R. S.; Smallwood, A.; Wong, P. C.; Rendina, A. R.; Luettgen, J. M.; Knabb, R. M.; He, K.; Xin, B. M.; Wexler, R. R.; Lam, P. Y. S., Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa. J. Med. Chem.2007, 50 (22), 5339-56. 55.(a) Oh, L. M., Synthesis of celecoxib via 1,3-dipolar cycloaddition. Tetrahedron Lett. 2006, 47 (45), 7943-6; (b) Donohue, S. R.; Halldin, C.; Pike, V. W., A facile and regioselective synthesis of rimonabant through an enamine-directed 1,3-dipolar cycloaddition. Tetrahedron Lett. 2008, 49 (17), 2789-91; (c) Chandanshive, J. Z.; Gonzalez, P. B.; Tiznado, W.; Bonini, B. F.; Caballero, J.; Femoni, C.; Franchini, M. C., 1,3-Dipolar cycloaddition of nitrile imines with alpha,beta-unsaturated lactones, thiolactones and lactams: synthesis of ring-fused pyrazoles. Tetrahedron 2012, 68 (16), 3319-28. 56.Luheshi, A.-B. N.; Smalley, R. K.; Kennewell, P.; Westwood, R., 1, 3-Dipolar cycloadditions of 2-ethoxy-and 2-(ethylthio)-1-azetines with nitrilimines. Tetrahedron Lett. 1990, 31 (1), 127-30. 57.Broggini, G.; Casalone, G.; Garanti, L.; Molteni, G.; Pilati, T.; Zecchi, G., Asymmetric induction by the (S)-1-phenylethyl group in intramolecular nitrile imine cycloadditions giving enantiopure 3,3a-dihydro-pyrazolo[1,5-alpha][1,4]benzodiazepine-4(6H)-ones. Tetrahedron-Asymmetr 1999, 10 (22), 4447-54. 58.(a) Grigorjeva, A.; Jirgensons, A.; Domracheva, I.; Yashchenko, E.; Shestakova, I.; Andrianov, V.; Kalvinsh, I., Synthesis of novel [1-aziridinyl-(hydroxyimino) methyl] arenes and their cytotoxic activity. Chem. Heterocycl. Compds. 2009, 45 (2), 161-8; (b) Ramon, R. S.; Bosson, J.; Diez-Gonzalez, S.; Marion, N.; Nolan, S. P., Au/Ag-cocatalyzed aldoximes to amides rearrangement under solvent- and acid-free conditions. J. Org. Chem.2010, 75 (4), 1197-202. 59.Resnati, G.; Soloshonok, V. A., Fluoroorganic chemistry: Synthetic challenges and biomedicinal rewards - Preface. Tetrahedron 1996, 52 (1), R13-R13. 60.Patel, D. V.; Riellygauvin, K.; Ryono, D. E.; Free, C. A.; Smith, S. A.; Petrillo, E. W., Activated ketone based inhibitors of human renin. J. Med. Chem.1993, 36 (17), 2431-47. 61.Jernigan, F. E.; Sieracki, N. A.; Taylor, M. T.; Jenkins, A. S.; Engel, S. E.; Rowe, B. W.; Jove, F. A.; Yap, G. P. A.; Papish, E. T.; Ferrence, G. M., Sterically bulky tris(triazolyl)borate ligands as water-soluble analogues of tris(pyrazolyl)borate. Inorg. Chem. 2007, 46 (2), 360-2. 62.Hwu, J. R.; Wong, F. F.; Huang, J. J.; Tsay, S. C., Sodium bis(trimethylsilyl)amide and lithium diisopropylamide in deprotection of alkyl aryl ethers: alpha-effect of silicon. J. Org. Chem. 1997, 62 (12), 4097-104. 63.Clark, R. C.; Pfeiffer, S. S.; Boger, D. L., Diastereoselective Diels-Alder reactions of N-sulfonyl-1-aza-1,3-butadienes with optically active enol ethers: an asymmetric variant of the 1-azadiene Diels-Alder reaction. J. Am. Chem. Soc. 2006, 128 (8), 2587-93. 64.Bai, J. F.; Guo, Y. L.; Peng, L.; Jia, L. N.; Xu, X. Y.; Wang, L. X., Enantioselective Diels-Alder reaction of anthrone and maleimide catalyzed by a simple chiral tertiary amine. Tetrahedron 2013, 69 (3), 1229-33. 65.Su, W. N.; Lin, T. P.; Cheng, K. M.; Sung, K. C.; Lin, S. K.; Wong, F. F., An efficient one‐pot synthesis of N‐(1,3‐diphenyl‐1H‐pyrazol‐5‐yl) amides. J. Heterocycl. Chem. 2010, 47 (4), 831-7. 66.Baraldi, P. G.; Simoni, D.; Periotto, V.; Manfredini, S.; Guarneri, M., Synthesis of 1-phenyl-substituted 3-methyl-1H-pyrazolo[3,4-b]pyrazine-5,6-dicarboxylic acid diethyl esters. Synthesis-Stuttgart 1984, (2), 148-9. 67.Orlov, V. D.; Tueni, M.; Kolos, N. N.; Getmanskii, N. V.; Kiroga, K., Reactions of 4,5-diamino-3-methyl-1-phenylpyrazole with aromatic haloketones. Khim Geterotsikl+ 1988, (6), 787-90. 68.Rizk, H. F.; El-Badawi, M. A.; Ibrahim, S. A.; El-Borai, M. A., Cyclization of 4,5-diamino pyrazole derivatives and their antibacterial activities. Chinese J Chem 2011, 29 (7), 1451-9. 69.Orlov, V.; Kiroga, K.; Kolos, N., Bispyrazole [3, 4-b∶ 4′, 3′-e] pyrazines as. self-condensation products from 4, 5-diaminopyrazoles. Chem. Heterocycl. Compds. 1988, 24 (9), 1008-12.
|